Cancer Cytopathology

Cancer Cytopathology

癌症细胞病理学

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Cancer Cytopathology》是由Wiley-Blackwell出版社于1948年创办的英文国际期刊(ISSN: 1934-662X,E-ISSN: 1934-6638),该期刊长期致力于病理学领域的创新研究,主要研究方向为医学-病理学。作为SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA未开放获取模式(OA占比0.0406...%),以发表病理学领域等方向的原创性研究为核心(研究类文章占比89.39%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在66篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Cancer Cytopathology审稿周期约为 约1月 。该刊近年未被列入国际预警名单,年发文量约66篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 66 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PATHOLOGY 病理学 ONCOLOGY 肿瘤学
2区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
PATHOLOGY 病理学 ONCOLOGY 肿瘤学
2区 3区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q3 175 / 322

45.8%

学科:PATHOLOGY SCIE Q2 35 / 88

60.8%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 109 / 322

66.3%

学科:PATHOLOGY SCIE Q2 36 / 88

59.66%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:7 SJR:0.991 SNIP:1.183
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q1 96 / 404

76%

大类:Medicine 小类:Cancer Research Q2 84 / 230

63%

期刊发文

  • Sputum cell-free DNA for detection of alterations of multiple driver genes in lung adenocarcinoma

    Author: Wang, Zheng; Li, Lin; Wang, Yifei; Li, Xiaoguang; Xu, Yan; Wang, Mengzhao; Liang, Li; Wu, Xiaonan; Tang, Min; Li, Yuanming; He, Shurong; Du, Jun; He, Lei; Sun, Mingjun; Yang, Li; Di, Jing; Gai, Fei; Liu, Dongge

    Journal: CANCER CYTOPATHOLOGY. 2023; Vol. 131, Issue 2, pp. 110-116. DOI: 10.1002/cncy.22644

  • Cutoff values of PD-L1 expression in urinary cytology samples for predicting response to immune checkpoint inhibitor therapy in upper urinary tract urothelial carcinoma

    Author: Chen, Ya; Fu, Jia; Li, Zhiyong; Chen, Qunxi; Zhang, Jing; Yang, Yuanzhong; Yang, Ping; Wang, Jiayu; Liu, Zhuowei; Cao, Yun; Zhang, Yijun

    Journal: CANCER CYTOPATHOLOGY. 2023; Vol. 131, Issue 3, pp. 179-187. DOI: 10.1002/cncy.22661

  • The role of cytology in densely populated territories: An experience from Hong Kong

    Author: Li, Joshua J. X.; Tse, Gary M.

    Journal: CANCER CYTOPATHOLOGY. 2023; Vol. 131, Issue 5, pp. 277-278. DOI: 10.1002/cncy.22668

  • Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting

    Author: Li, Yan; Salama, Abeer M.; Baine, Marina K.; Bodd, Francis M.; Offin, Michael D.; Rekhtman, Natasha; Zauderer, Marjorie G.; Travis, William D.; Adusumilli, Prasad S.; Sauter, Jennifer L.

    Journal: CANCER CYTOPATHOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1002/cncy.22705

  • Claudin18.2 expression and clinicopathological features in cytology effusion specimens from gastric adenocarcinoma: A comparative study with tissue specimens

    Author: Dai, Jiao; Zheng, Heng; Jin, Ju; Cheng, Ye; Xu, Haimiao

    Journal: CANCER CYTOPATHOLOGY. 2023; Vol. , Issue , pp. -. DOI: 10.1002/cncy.22688

  • Automated detection of cancer cells in effusion specimens by DNA karyometry.

    Author: Böcking AH1,2, Friedrich D3,4, Meyer-Ebrecht D3, Zhu C5, Feider A6, Biesterfeld S7.

    Journal: Cancer Cytopathol. 2019 Feb;127(1):18-25. doi: 10.1002/cncy.22072. Epub 2018 Oct 19.

  • The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries.

    Author: Agarwal S1, Bychkov A2, Jung CK3, Hirokawa M4, Lai CR5, Hong S6, Kwon HJ6, Rangdaeng S7, Liu Z8,9, Su P9, Kakudo K10, Jain D1.

    Journal: Cancer Cytopathol. 2019 Mar;127(3):181-191. doi: 10.1002/cncy.22101. Epub 2019 Jan 22.

  • Follow-up with histopathology and HPV testing on LSIL cytology in China's largest academic woman's hospital.

    Author: Tao X1, Zhang H2, Zhang H1, Xiao J1, Li J3, Zhou X1, Wang L1, Zhao C1,4.

    Journal: Cancer Cytopathol. 2019 Apr;127(4):258-266. doi: 10.1002/cncy.22119. Epub 2019 Mar 20.